The CX3C-chemokine fractalkine in kidney diseases

Mini-Reviews in Medicinal Chemistry

Volumn 9, Issue 10, 2009, Pages 1215-1228

  Koziolek, M J ^a   Vasko, R ^a   Bramlage, C ^a   Muller G A ^a   Strutz, F ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Acute renal failure; Chemotaxis; Chronic renal failure; Fractalkine; Inflammation; Nephrogenesis; Renal transplantation; Tubulointerstitial fibrosis

Indexed keywords

CD16 ANTIGEN; CHEMOKINE; CISPLATIN; CONNECTIVE TISSUE GROWTH FACTOR; CREATININE; CX3C CHEMOKINE; CYCLOSPORIN A; FRACTALKINE; GLUCOCORTICOID; INTERLEUKIN 1BETA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ANCA ASSOCIATED VASCULITIS; BIOLOGICAL ACTIVITY; CD3+ T LYMPHOCYTE; CELL INFILTRATION; CELL POPULATION; CELLULAR DISTRIBUTION; CHRONIC FOLIC ACID NEPHROPATHY; CHRONIC KIDNEY FAILURE; COLLAPSING GLOMERULOPATHY; DIABETIC NEPHROPATHY; ENDOSOME; ENDOTHELIUM CELL; FOCAL GLOMERULOSCLEROSIS; GLOMERULONEPHRITIS; GLOMERULOPATHY; GLOMERULUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; KIDNEY ALLOGRAFT REJECTION; KIDNEY CORTEX; KIDNEY DEVELOPMENT; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INTERSTITIUM; KIDNEY ISCHEMIA; KIDNEY MEDULLA; KIDNEY PROXIMAL TUBULE; KIDNEY TRANSPLANTATION; KIDNEY TUBULE EPITHELIUM; LEUKOCYTE MIGRATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MESANGIUM CELL; NEPHRON; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEINURIA; REPERFUSION INJURY; REVIEW; SEPSIS;

ANIMALS; CHEMOKINE CX3CL1; GENE EXPRESSION REGULATION; HUMANS; KIDNEY DISEASES; RECEPTORS, CYTOKINE; RECEPTORS, HIV;

EID: 70450214085     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955709789055252     Document Type: Review

References (85)

1. Holdsworth, S.R.; Kitching, A.R.; Tipping, P.G. Chemokines as therapeutic targets in renal disease. Curr. Opin. Nephrol. Hypertens., 2000, 9, 505-511.
2. Nanki, T.; Imai, T.; Nagasaka, K.; Urasaki, Y.; Nonomura, Y.; Taniguchi, K.; Hayashida, K.; Hasegawa, J.; Yoshie, O.; Miyasaka, N. Migration of CX3CR1-positive T cells producing type 1 cytolytic and cytotoxic molecules into the synovium of patients with rheumatoid arthritis. Arthritis Rheumatol., 2002, 46, 2878-2883. (Pubitemid 35315878)
3. Anders, H.J.; Vielhauer, V.; Schlöndorff, D. Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int., 2003, 63, 401-415. (Pubitemid 36126787)
4. Braunersreuther, V.; Mach, F.; Steffens, S. The specific role of chemokines in atherosclerosis. Thromb. Haemost., 2007, 97, 714-721.
5. Viola, A.; Luster, A.D. Chemokines and their receptors: drug targets in immunity and inflammation. Annu. Rev. Pharmacol. Toxicol., 2008, 48, 171-197. (Pubitemid 351756361)
6. (a) Olson, T.S.; Ley, K. Chemokines and chemokine receptors in leukocyte trafficking. Am. J. Physiol., 2002, 281(1), R7-R298.
7. (b) Frangogiannis, N.G. Chemokines in ischemia and reperfusion. Thromb. Haemost., 2007, 97, 738-747.
8. Furuichi, K.; Gao, J.L.; Murphy, P.M. Chemokine receptor CX3CR1 regulates renal interstitial fibrosis after ischemia-reperfusion injury. Am. J. Pathol., 2006, 169, 372-387.
9. Koziolek, M.J.; Schmid, H.; Cohen, C.; Blaschke, S.; Hemmerlein, B.; Zapf, A.; Müller, G.A.; Strutz, F. Potential role of fractalkine receptor (CX3C-R) expression in human renal fibrogenesis. Kidney Int., 2007, 72, 599-607. (Pubitemid 47312792)
10. Nomiyama, H.; Imai, T.; Kusuda, J.; Miura, R.; Callen, D.F.; Yoshie, O. Human chemokines fractalkine (SCYD1), MDC (SCYA22) and TARC (SCYA17) are clustered on chromosome 16q13. Cytogenet. Cell. Genet., 1998, 81, 10-11. (Pubitemid 28380092)
11. 3C motif. Nature, 1997, 385, 640-644.
12. Liu, G.Y.; Kulasingam, V.; Alexander, R.T.; Touret, N.; Fong, A.M.; Patel, D.D.; Robinson, L.A. Recycling of the membrane anchored chemokine, CX3CL1. J. Bol. Chem., 2005, 280, 19858-19866.
13. Imaizumi, T.; Matsumiya, T.; Fujimoto, K.; Okamoto, K.; Cui, X.; Ohtaki, U.; Yoshida, H.; Satoh, K. Interferon-γ stimulates the expression of CX3CL1/fractalkine in cultured human endothelial cells. Tohoku J. Exp. Med., 2000, 192, 127-139. (Pubitemid 33621585)
14. Durkan, A.M.; Alexander, R.T.; Liu, G.Y.; Rui, M.; Femia, G.; Robinson, L.A. Expression and targeting of CX3CL1 (fractalkine) in renal tubular epithelial cells. J. Am. Soc. Nephrol., 2007, 18, 74-83.
15. Ludwig, A.; Weber, C. Transmembrane chemokines: Versatile 'special agents' in vascular inflammation. Thromb. Haemost., 2007, 97, 694-703.
16. 3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J. Exp. Med., 1998, 188, 1413-1419.
17. Imai, T.; Hieshima, K.; Haskell, C.; Baba, M.; Nagira, M.; Nishimura, M.; Kakizaki, M.; Takagi, S.; Nomiyama, H.; Schall, T.J.; Yoshie, O. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediated both leukocyte migration and adhesion. Cell, 1997, 91, 521-530.
18. Foussat, A.; Coulomb-L'Hermine, A.; Gosling, J.; Krzysiek, R.; Durand-Gasselin, I.; Schall, T.; Balian, A.; Richard, Y.; Galanaud, P.; Emilie, D. Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human. Eur. J. Immunol., 2000, 30, 87-97. (Pubitemid 30011769)
19. Efsen, E.; Grappone, C.; DeFranco, R.M.; Milani, S.; Romanelli, R.G.; Bonacchi, A.; Caligliuri, A.; Failli, P.; Annunziato, F.; Pagliai, G.; Pinzani, M.; Laffi, G.; Gentilini, P.; Marra, F. Upregulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans. J. Hepatol., 2002, 37, 39-47.
20. Brand, S.; Sakaguchi, T.; Gu, X.; Colgan, S.P.; Reinecker, H.C. Fractalkine-mediated signals regulate cell-survival and immunemodulatory responses in intestinal epithelial cells. Gastroenterology, 2002, 122, 166-177.
21. Wong, B.W.; Wong, D.; McManus, B.M. Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease. Cardiovasc. Pathol., 2002, 11, 332-338.
22. Perros, F.; Dorfmüller, P.; Souza, R.; Durand-Gasselin, I.; Godot, V.; Capel, F.; Adnot, S.; Eddahibi, S.; Mazmanian, M.; Fadel, E.; Hervé, P.; Simonneau, G.; Emilie, D.; Humbert, M. Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension. Eur. Respir. J., 2007, 29, 937-943.
23. Ji, J.F.; He, B.P.; Dheen, S.T.; Tay, S.S. Interacion of chemokines and chemokine receptors mediated migrationb of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells, 2004, 22, 415-427.
24. 3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms. J. Immunol., 2000, 164, 4313-4320.
25. Haskell, C.A.; Cleary, M.D.; Charo, I.F. Unique role of the chemokine domain of fractalkine in cell capture. J. Biol. Chem., 2000, 275, 34183-34189.
26. Matsubara, T.; Ono, T.; Yamanoi, A.; Tachibana, M.; Nagasue, N. Fractalkine-CX3CR1 axis regulates tumor cell cycle and deteriorates prognosis after radical resection for hepatocellular carcinoma. J. Surg. Oncol., 2007, 95, 241-249. (Pubitemid 46310017)
27. 3CL1) in rheumatoid arthritis. J. Rheumatol., 2003, 30(9), 1918-1927.
28. 3CL1). Circulation, 2003, 108, 2498-2504.
29. Maciejewski-Lenoir, D.; Chen, S.; Feng, L.; Maki, R.; Bacon, K.B. Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. J. Immunol., 1999, 163, 1628-1635.
30. Zujovic, V.; Benavides, J.; Vigé, X.; Carter, C.; Taupin, V. Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. Glia, 2000, 29, 305-315. (Pubitemid 30121421)
31. Schäfer, A.; Schulz, C.; Fraccarollo, D.; Tas, P.; Leutke, M.; Eigenthaler, M.; Seidl, S.; Heider, P.; Ertl, G.; Massberg, S.; Bauersachs, J. The CX3C chemokine fractalkine induces vascular dysfunction by generation of superoxide anions. Arterioscler. Thromb. Vasc. Biol., 2007, 27, 55-62. (Pubitemid 46360381)
32. Gröne, H.J.; Cohen, C.D.; Gröne, E.; Schmidt, C.; Kretzler, M.; Schlöndorff, D.; Nelson, P.J. Spatial and temporally restricted expression of chemokines and chemokine receptors in the developing kidney. J. Am. Soc. Nephrol., 2002, 13, 957-967. (Pubitemid 34274092)
33. 3CR1) in human kidney diseases. Kidney Int., 2002, 62, 488-495.
34. Chen, Y.M.; Hu-Tsai, M.I.; Lin, S.L.; Tsai, T.J.; Hsieh, B.S. Expression of CX3CL1/fractalkine by mesangial cells in vitro and in acute anti-Thy1 glomerulonephritis in rats. Nephrol. Dial. Transplant., 2003, 18, 2505-2514.
35. Yoshimoto, S.; Nakatani, K.; Iwano, M.; Asai, O.; Samejima, K.; Sakan, H.; Terada, M.; Harada, K.; Akai, Y.; Shiiki, H.; Nose, M.; Saito, Y. Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis. Am. J. Kidney Dis., 2007, 50, 47-58. (Pubitemid 46970800)
36. Qing, X.; Zavadil, J.; Crosby, M.B.; Hogarth, M.P.; Hahn, B.H.; Mohan, C.; Gilkeson, G.S.; Bottinger, E.P.; Putterman, C. Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis Rheumatol., 2006, 54, 2198-2210. (Pubitemid 44051076)
37. Furuichi, K.; Wada, T.; Iwata, Y.; Sakai, N.; Yoshimoto, K.; Shimizu, M.; Kobayashi, K.; Takasawa, K.; Kida, H.; Takeda, S.; Matsushima, K.; Yokoyama, H. Upregulation of fractalkine in human crescentic glomerulonephritis. Nephron, 2001, 87, 314-320. (Pubitemid 32260831)
38. Tam, F.W.; Sanders, J.S.; George, A.; Hammad, T.; Miller, C.; Dougan, T.; Cook, H.T.; Kallenberg, C.G.; Gaskin, G.; Levy, J.B.; Pusey, C.D. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis. Nephrol. Dial. Transplant., 2004, 19, 2761-2768.
39. 3CR1. Rapid Communication. Kidney Int., 1999, 56, 612-620.
40. Kikuchi, Y.; Ikee, R.; Hemmi, N.; Hyodo, N.; Saigusa, T.; Namikoshi, T.; Yamada, M.; Suzuki, S.; Miura, S. Fractalkine and its receptor, CX3CR1, upregulation in streptozotocin-induced diabetic kidneys. Nephron Exp. Nephrol., 2004, 97, e17-25.
41. Kikuchi, Y.; Imakiire, T.; Hyodo, T.; Kushiyama, T.; Higashi, K.; Hyodo, N.; Suzuki, S.; Miura, S. Advanced glycation end-product induces fractalkine gene upregulation in normal rat glomeruli. Nephrol. Dial. Transplant., 2005, 20, 2690-2696. (Pubitemid 41672267)
42. Beck, G.Ch.; Ludwig, F.; Schulte, J.; van Ackern, K.; van der Woude, F.J.; Yard, B.A. Fractalkine is not a major chemoattractant for the migration of neutrophils across microvascular endothelium. Scand. J. Immunol., 2003, 58, 180-187.
43. Zanchi, C.; Zoja, C.; Morigi, M.; Valsecchi, F.; Liu, X.Y.; Rottoli, D.; Locatelli, M.; Buelli, S.; Pezzotta, A.; Mapelli, P.; Geelen, J.; Remuzzi, G.; Hawiger, J. Fractalkine and CX3CR1 mediate leukocyte capture by endothelium in response to shiga toxin. J. Immunol., 2008, 181, 1460-1469.
44. Oh, D.J.; Dursun, B.; He, Z.; Lu, L.; Hoke, T.S.; Ljubanovic, D.; Faubel, S.; Edelstein, C.L. Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice. Am. J. Physiol. Renal Physiol., 2008, 294, F264-271.
45. Lu, L.H.; Oh, D.J.; Dursun, B.; He, Z.; Hoke, T.S.; Faubel, S.; Edelstein, C.L. Increased macrophage infiltration and fractalkine expression in cisplatin-induced acute renal failure in mice. J. Pharmacol. Exp. Ther., 2008, 324, 111-117. (Pubitemid 350294166)
46. Donadelli, R.; Zanchi, C.; Morigi, M.; Buelli, S.; Batani, C.; Tomasoni, S.; Corna, D.; Rottoli, S.; Benigni, A.; Abbate, M.; Remuzzi, G.; Zoja, C. Protein overload induces fractalkine upregulation in proximal tubular cells through nuclear factor kappa B- and p38 mitogen-activated protein kinase-dependent pathways. J. Am. Soc. Nephrol., 2003, 13, 2436-2446. (Pubitemid 37169329)
47. Cockwell, P.; Calderwood, J.W.; Brooks, C.J.; Chakravorty, S.J.; Savage, C.O. Chemoattraction of T cells expressing CCR5, CXCR3 and CX3CR1 by proximal tubular epithelial cell chemokines. Nephrol. Dial. Transplant., 2002, 17, 734-744.
48. Cao, G.; Lu, Y.; Gao, R.; Xin, Y.; Teng, D.; Wang, J.; Li, Y. Expression of fractalkine, CX3CR1, and vascular endothelial growth factor in human chronic renal allograft rejection. Transplant. Proc., 2006, 38, 1998-2000. (Pubitemid 46068504)
49. Pietrzyk, M.C.; Banas, B.; Wolf, K.; Rummele, P.; Woenckhaus, M.; Hoffmann, U.; Kramer, B.K.; Fischereder, M. Quantitative gene expression analysis of fractalkine using laser microdissection in biopsies from kidney allografts with acute rejection. Transplant. Proc., 2004, 36, 2659-2661. (Pubitemid 40036804)
50. Peng, W.; Chen, J.; Jiang, Y.; Wu, J.; Shou, Z.; He, Q.; Wang, Y.; Chen, Y.; Wang, H. Urinary fractalkine is a marker of acute rejection. Kidney Int., 2008, 74, 1454-1460.
51. Cao, G.; Lu, Y.; Gao, R.; Xin, Y.; Teng, D.; Wang, J.; Wang, L.; Li, Y. Comparison of cyclosporine versus mycophenolate mofetil on expression of fractalkine and CX3CR1 in chronic allograft nephropathy. Transplant. Proc., 2006, 38, 2234-2236. (Pubitemid 46068492)
52. Wynn, T.A. Cellular and molecular mechanisms of fibrosis. J. Pathol., 2008, 214, 199-210.
53. Ishida, Y.; Gao, J.L.; Murphy, P.M. Chemokine receptor CX3C-R mediates skin wound healing by promoting macrophage and fibroblast accumulation and function. J. Immunol., 2008, 180, 569-579.
54. Wasmuth, H.E.; Zaldivar, M.M.; Berres, M.L.; Werth, A.; Scholten, D.; Hillebrandt, S.; Tacke, F.; Schmitz, P.; Dahl, E.; Wiederholt, T.; Hellerbrand, C.; Berg, T.; Weiskirchen, R.; Trautwein, C.; Lammert, F. The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection. J. Hepatol., 2008, 48, 208-215.
55. Kruse, J.J.; Bomhoff-Wijdenes, I.F.; Poele, J.A.; Stewart, F.A. Fractalkine: an important candidate for directing periglomerular leukocyte accumulation in irradiated mouse kidneys. Acta Oncol., 2007, 46, 945-950.
56. Wu, S.H.; Wu, X.H.; Lu, C.; Dong, L.; Zhou, G.P.; Chen, Z.Q. Lipoxin A4 inhibits connective tissue growth factor-induced production of chemokines in rat mesangial cells. Kidney Int., 2006, 69, 248-256. (Pubitemid 43323074)
57. Faure, V.; Cerini, C.; Paul, P.; Berland, Y.; Dignat-George, F.; Brunet, P. The uremic solute p-cresol decreases leukocyte transendothelial migration in vitro. Int. Immunol., 2006, 18, 1453-1459. (Pubitemid 44446823)
58. Hasegawa, M.; Sato, S.; Echigo, T.; Hamaguchi, Y.; Yasui, M.; Takehara, K. Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis. Ann. Rheum. Dis., 2005, 64, 21-28. (Pubitemid 40075269)
59. Husberg, C.; Nygård, S.; Finsen, A.V.; Damås, J.K.; Frigessi, A.; Oie, E.; Wæhre, A.; Gullestad, L., Aukrust, P.; Yndestad, A.; Christensen, G. Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure. J. Mol. Cell. Cardiol., 2008, 45, 261-269.
60. Ito, T. Can measurement of chemokines become useful biological and functional markers of early-stage chronic pancreatitis? J. Gastroenterol., 2007, 42, 72-77. (Pubitemid 46140370)
61. Saederup, N.; Chan, L.; Lira, S.A.; Charo, I.F. Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis. Circulation, 2008, 117, 1642-1648.
62. Hannan, N.J.; Salamonsen, L.A. CX3CL1 and CCL14 regulate extracellular matrix and adhesion molecules in the trophoblast: potential roles in human embryo implantation. Biol. Reprod., 2008, 79, 58-65.
63. Klosowska, K.; Volin, M.V.; Huynh, N.; Chong, K.K.; Halloran, M.M.; Woods, J.M. Fractalkine functions as a chemoattractant for osteoarthritis synovial fibroblasts and stimulates phosphorylation of mitogen-activated protein kinases and Akt. Clin. Exp. Immunol., 2009, 156, 312-319.
64. Dichmann, S.H.Y.; Purlis, D.; Rheinen, H.; Gebicke-Härter, P.; Norgauer, J. Fractalkine induces chemotaxis and actin polymerization in human dendritic cells. Inflamm. Res., 2001, 50, 528-533. (Pubitemid 33121899)
65. 3CL1) stimulated by nuclear factor kappa B (NF-B)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway. Biochem. J., 2003, 373, 547-558.
66. Combadière, C.; Potteaux, S.; Gao, J.L.; Esposito, B.; Casanova, S.; Lee, E.J.; Debré, P.; Tedgui, A.; Murphy, P.M.; Mallat, Z. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation, 2003, 107, 1009-1016. (Pubitemid 36258725)
67. Chen, Y.M.; Tu, C.J.; Hung, K.Y.; Wu, K.D.; Tsai, T.J.; Hsieh, B.S. Inhibition by pentoxifylline of TNFα-stimulated fractalkine production in vascular smooth muscle cells: evidence for mediation by NF-κB down regulation. Br. J. Pharmacol., 2003, 238, 950-958.
68. Chen, Y.M.; Lin, S.L.; Chen, C.W.; Chiang, W.C.; Tsai, T.J.; Hsieh, B.S. Tumor necrosis factor-alpha stimulates fractalkine production by mesangial cells and regulates monocyte transmigration: down-regulation by cAMP. Kidney Int., 2003, 63, 474-486.
69. Patel, A.; Jagadesham, V.P.; Porter, K.E.; Scott, D.J.; Carding, S.R. Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease. Eur. J. Vasc. Endovasc. Surg., 2008, 36, 20-27.
70. 3CL1) as a membrane-anchored proadhesive protein and soluble chemotactic peptide on human fibroblasts. FEBS Lett., 2004, 561, 105-111.
71. Matsumiya, T.; Imaizumi, T.; Fujimoto, K.; Cui, X.; Shibata, T.; Tamo, W.; Kumagai, M.; Tanji, K.; Yoshida, H.; Kimura, H.; Satoh, K. Soluble Interleukin-6 receptor α inhibits the cytokine-induced Fractalkine/CX3CL1 expression in human vascular endothelial cells in culture. Exp. Cell. Res., 2001, 269, 35-41.
72. Sandell, L.J.; Xing, X.; Franz, C.; Davies, S.; Chang, L.W.; Patra, D. Exuberant expression of chemokine genes by adult human articular chondrocytes in response to IL-1beta. Osteoarthritis Cartilage, 2008, 16, 1560-1571.
73. Greaves, D.R.; Häkkinen, T.; Lucas, A.D.; Liddiard, K.; Jones, E.; Quinn, C.M.; Senaratne, J.; Green, F.R.; Tyson, K.; Boyle, J.; Shanahan, C.; Weissberg, P.L.; Gordon, S.Y. Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus and activation-regulated chemokine, are expressed in human atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol., 2001, 21, 923-929.
74. Wu, S.H.; Lu, C.; Dong, L.; Chen, Z.Q. Signal transduction involved in CTGF-induced production of chemokines in mesangial cells. Growth Factors, 2008, 26, 192-200.
75. Imaizumi, T.; Matsumiya, T.; Tamo, W.; Shibata, T.; Fujimoto, K.; Kumagai, M.; Yoshida, H.; Cui, X.F.; Tanji, K.; Hatakeyama, M.; Wakabayashi, K.; Satoh, K. 15-Deoxy-D12,14-prostaglandin J2 inhibits CX3CL1/fractalkine expression in human endothelial cells. Immunol. Cell. Biol., 2002, 80, 531-536.
76. Hatakeyama, M.; Imaizumi, T.; Tamo, W.; Yamashita, K.; Yoshida, H.; Fukuda, I.; Satoh, K. Heparin inhibits IFN-gammainduced fractalkine/CX3CL1 expression in human endothelial cells. Inflammation, 2004, 28, 7-13. (Pubitemid 38249274)
77. Popovic, M.; Laumonnier, Y.; Burysek, L.; Syrovets, T.; Simmet, T. Thrombin-induced expression of endothelial CX3CL1 potentiates monocyte CCL2 production and transendothelial migration. J. Leukoc. Biol., 2008, 84, 215-223. (Pubitemid 351960297)
78. Gerstung, M.; Roth, T.; Dienes, H.P.; Licht, C.; Fries, J.W. Endothelin-1 induces NF-kappaB via two independent pathways in human renal tubular epithelial cells. Am. J. Nephrol., 2007, 27, 294-300.
79. Bhavsar, P.K.; Sukkar, M.B.; Khorasani, N.; Lee, K.Y.; Chung, K.F. Glucocorticoid suppression of CX3CL1 (fractalkine) by reduced gene promoter recruitment of NF-κB. FASEB J., 2008, 22.
80. Banerjee, A.; Damera, G.; Bhandare, R.; Gu, S.; Lopez-Boado, Y.S.; Panettieri, R.A. Jr.; Tliba, O. Vitamin D and glucocorticoids differentially modulate chemokine expression in human airway smooth muscle cells. Br. J. Pharmacol., 2008, 155, 84-92.
81. Zhao, P.; De, A.; Hu, Z.; Li, J.; Mulders, S.M.; Sollewijn Gelpke, M.D.; Duan, E.K.; Hsueh, A.J. Gonadotropin stimulation of ovarian fractalkine expression and fractalkine augmentation of progesterone biosynthesis by luteinizing granulosa cells. Endocrinology, 2008, 149, 2782-2789.
82. Green, S.R.; Han, K.H.; Chen, Y.; Almazan, F.; Charo, I.F.; Miller, Y.I.; Quehenberger, O. The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK. J. Immunol., 2006, 176, 7412-7420. (Pubitemid 43849043)
83. Saitoh, Y.; Koizumi, K.; Sakurai, H.; Minami, T.; Saiki, I. RANKL-induced down-regulation of CX3CR1 via PI3K/Akt signaling pathway suppresses Fractalkine/CX3CL1-induced cellular responses in RAW264.7 cells. Biochem. Biophys. Res. Commun., 2007, 364, 417-422. (Pubitemid 350030917)
84. 3CR1 expression and inhibits fractalkine-stimulated signaling in rat microglia. J. Neuroimmunol., 2002, 133, 46-55.
85. Boddeke, E.W.; Meigel, I.; Frentzel, S.; Biber, K.; Renn, L.Q.; Gebicke-Härter, P. Functional expression of the fractalkine (CX3C) receptor and its regulation by lipopolysaccharide in rat microglia. Eur. J. Pharmacol., 1999, 374, 309-313. (Pubitemid 29287147)